PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
15 mai 2024 08h30 HE
|
PaxMedica, Inc.
TARRYTOWN, New York, May 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (the “Company” or “PaxMedica”) (OTC:PXMD), a biopharmaceutical company dedicated to advancing treatments for...
Hopebridge Launches New Localized Clinical Support Structure and Expands Renowned Fellowship Program to Contribute to Growth and Development of the ABA Workforce
10 mai 2024 08h00 HE
|
Hopebridge
INDIANAPOLIS, IN, May 10, 2024 (GLOBE NEWSWIRE) -- Hopebridge, a leading provider of pediatric therapy services, is excited to unveil its latest evolution in clinical support with the launch of a...
NeuroSigma Announces Acceptance into 2024 Cohort of the KidsX Accelerator Program
09 mai 2024 09h00 HE
|
NeuroSigma, Inc.
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced its acceptance into the 2024 cohort of the KidsX Accelerator Program. KidsX is a global leader in pediatric digital...
Disability-friendly family camp currently accepting applications
30 avr. 2024 10h00 HE
|
Joni and Friends
Lexington, Nebraska, April 30, 2024 (GLOBE NEWSWIRE) -- When you have a loved one with a disability, taking a family vacation can feel impossible. That’s why Joni and Friends, an international...
Global Psychiatry Collaboration and Licensing Deals Directory, 2019-2024: Deal Trends, Leading Deals by Value, Most Active Dealmakers, Financials Terms, and More
26 avr. 2024 10h16 HE
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Psychiatry Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Psychiatry Collaboration and...
Hopebridge Gears Up for World Autism Month, Spreads Awareness of 1 in 36 Autism Prevalence
25 mars 2024 09h00 HE
|
Hopebridge
Indianapolis, IN, March 25, 2024 (GLOBE NEWSWIRE) -- INDIANAPOLIS, IN (March 25, 2024) -- As autism prevalence continues to rise, most recently reported as 1 in 36 from the CDC, the importance of...
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder
08 mars 2024 07h11 HE
|
SciSparc Ltd
TEL AVIV, Israel, March 08, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing
29 févr. 2024 08h35 HE
|
SciSparc Ltd
The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in accordance with enrollment initiation TEL AVIV, Israel, Feb. 29,...
Bierman Autism Centers Elevates Inclusive Play at Eatontown's 80 Acre Park with AAC Board Donation
22 févr. 2024 05h00 HE
|
Bierman Autism Centers
Eatontown, N.J., Feb. 22, 2024 (GLOBE NEWSWIRE) -- In a heartwarming gesture of inclusivity, Bierman Autism Centers (Bierman) announces the donation of an Augmentative and Alternative Communication...
BlueSprig Pediatrics Sponsors Armani Williams Ahead of the Daytona ARCA 200
12 févr. 2024 09h00 HE
|
BlueSprig Pediatrics, Inc.
DAYTONA BEACH, Fla., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Blue Sprig Pediatrics, Inc. (BlueSprig), a leader in Applied Behavior Analysis (ABA) therapy for children diagnosed with Autism Spectrum...